Chesley Taft & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $363K | Buy |
3,274
+974
| +42% | +$108K | 0.02% | 282 |
|
|
2025
Q1 | $258K | Buy |
+2,300
| New | +$258K | 0.01% | 311 |
|
|
2017
Q4 | – | Sell |
-5,000
| Closed | -$405K | – | 286 |
|
|
2017
Q3 | $405K | Buy |
5,000
+1,840
| +58% | +$149K | 0.04% | 233 |
|
|
2017
Q2 | $224K | Sell |
3,160
-200
| -6% | -$14.2K | 0.02% | 264 |
|
|
2017
Q1 | $228K | Sell |
3,360
-245
| -7% | -$16.6K | 0.02% | 261 |
|
|
2016
Q4 | $258K | Sell |
3,605
-845
| -19% | -$60.5K | 0.03% | 251 |
|
|
2016
Q3 | $352K | Sell |
4,450
-12,405
| -74% | -$981K | 0.04% | 218 |
|
|
2016
Q2 | $1.41M | Sell |
16,855
-275
| -2% | -$22.9K | 0.14% | 124 |
|
|
2016
Q1 | $1.57M | Sell |
17,130
-88,411
| -84% | -$8.12M | 0.17% | 114 |
|
|
2015
Q4 | $10.7M | Sell |
105,541
-59,280
| -36% | -$6M | 1.12% | 25 |
|
|
2015
Q3 | $16.2M | Buy |
164,821
+600
| +0.4% | +$58.9K | 1.77% | 13 |
|
|
2015
Q2 | $19.2M | Buy |
164,221
+3,780
| +2% | +$443K | 1.96% | 9 |
|
|
2015
Q1 | $15.7M | Buy |
160,441
+30,586
| +24% | +$3M | 1.62% | 15 |
|
|
2014
Q4 | $12.2M | Sell |
129,855
-14,250
| -10% | -$1.34M | 1.24% | 25 |
|
|
2014
Q3 | $15.3M | Sell |
144,105
-162
| -0.1% | -$17.2K | 1.61% | 12 |
|
|
2014
Q2 | $12M | Buy |
144,267
+9,655
| +7% | +$800K | 1.24% | 22 |
|
|
2014
Q1 | $9.54M | Sell |
134,612
-1,650
| -1% | -$117K | 1.02% | 32 |
|
|
2013
Q4 | $10.2M | Buy |
136,262
+3,775
| +3% | +$283K | 1.02% | 31 |
|
|
2013
Q3 | $8.33M | Buy |
132,487
+8,762
| +7% | +$551K | 0.91% | 37 |
|
|
2013
Q2 | $6.34M | Buy |
+123,725
| New | +$6.34M | 0.74% | 42 |
|